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LETTERS TO THE EDITOR
Antioxidants in Chinese Green Tea
Woo et al. (1) found that although endothelium-dependent dilation is
similar in the arteries of healthy young Chinese and white adults in
Australia, with older age Chinese subjects are less susceptible to
impaired endothelial function. The mechanism of age-related endo-
thelial dysfunction in whites is unknown. But Woo et al. postulated
that green tea, of which the Chinese consume a great deal, is rich in
antioxidants and may play a role.
Actually, the antioxidant effect is not limited to green tea. In China,
tea has been considered a crude medicine for 4,000 years. Different
types of pharmacologic effects, such as protection of blood vessels,
reduction of serum cholesterol levels and prevention of atherosclero-
sis, have been reported as an integrated effect (2). Green tea is a staple
product and is the main beverage in China. However, other Chinese
teas also possess antioxidant activities.
Ho et al. (3) studied 12 tea products, including six green teas, four
semifermented teas and two black teas, all obtained from China. They
found that, in general, green tea extracts showed stronger antioxidant
activity than the semifermented and black tea extracts, mainly due to
the higher content of (2)-epigallocatechin gallate. The good antioxi-
dant activities of black tea extract may be due to gallic acid, which is
more abundant in black tea extracts. The caffeine in the tea had no
antioxidant activity at all.
Thus, aging is not inevitably associated with progressive arterial
dysfunction in all humans, and cardiovascular disease is not just
genetic. Besides green tea, there must be some other environmental
factors that are important. If we could only find out what it is that
protects the Chinese and apply it in the West, we would have a very
significant breakthrough.
TSUNG O. CHENG, MD, FACC
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Predicting Mortality After Coronary Artery
Bypass Graft Surgery
I read with interest the report by Jones et al. for the Working Group
Panel on the Cooperative CABG Database Project (1) on identifying
the preoperative variables needed for risk adjustment of short-term
mortality after coronary artery bypass graft surgery (CABG). The
authors of this consensus report concluded that a small number of
clinical variables provide a large amount of prognostic information in
patients undergoing CABG. In Ontario, Canada, we have reached
similar conclusions, based on our analysis of data from the Cardiac
Care Network (CCN) of Ontario cardiac surgery registry (2,3). This
population-based registry contains data on all patients undergoing
cardiac surgery in Ontario since 1991. We have observed that five of
the seven core variables identified by Jones et al. (i.e., age, female
gender, emergency surgery, reoperation and left ventricular function)
are consistent predictors of in-hospital mortality after isolated CABG
each year that we have analyzed the data. Variables describing
coronary anatomy (i.e., left main disease and number of diseased
vessels), the two other core variables identified in this report, have
proved to be significant in some years but not in others. We have
developed a simple risk index based on integer risk scores using these
core variables and have shown that it predicts mortality, intensive care
unit stay and postoperative length of stay after cardiac surgery at all
nine cardiac surgery hospitals in Ontario (2). Accordingly, we agree
with Jones et al. on the value of standardizing the definition of data
base variables and focusing on collecting a small number of the most
important variables.
Although we recognize the importance of some of the level 1
variables (e.g., chronic obstructive pulmonary disease, diabetes) listed
in this report in individual patients, we have observed that adjusting for
these variables usually does not have a substantial effect on risk-
adjusted mortality rates after we have statistically adjusted for the core
variables listed in this report. Relatively rare surgical risk factors, such
as renal failure, may be important in the individual patient but do not
usually affect overall results because of their low frequency in the
general population of patients undergoing CABG.
Previous work by panel members (4–7) and others has been very
valuable to us in our efforts to design a simple, yet valid risk assessment
model for cardiac surgery. Whether it will be possible to develop a
common preoperative risk model based on universally accepted vari-
able definitions remains to be seen. However, the publication of this
report by the Working Group Panel on the Cooperative CABG
Database Project represents an important first step toward achieving
this worthwhile objective.
JACK V. TU, MD, PHD, FRCPC
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Myocardial Viability
The major reason why a clinical cardiologist pursues myocardial
viability is to reduce cardiovascular mortality. Although there are no
data about it, the rationale basis is the preservation of ventricular
function by the identification of reversible regional myocardial dys-
function, leading to a lower risk of death, assuming that the better the
ejection fraction the lower the mortality. The problem rests on the
risk/benefit ratio. The risk is to revascularize through bypass surgery or
coronary angioplasty, taking into account clinical condition, inherent
procedural complications, mortality and restenosis rates. In the case of
coronary angioplasty, low flow conditions may lead to hybernating
myocardium. There are widely available data about myocardial viabil-
ity but none answering the question of how much viable myocardium
is worth justifying the risk of the revascularization procedure and a
significant increase in ejection fraction. It seems that we have a long
way to go because the accepted documentation of viable myocardium
is made just after revascularization, and there is no “gold standard”
method for predicting reversibility of contractile dysfunction. Elhendy
et al. (1) in a recent issue of the Journal observed that 14 patients with
reversible single-photon emission computed tomographic imaging
perfusion defects had no evidence of myocardial ischemia as assessed
by wall motion abnormalities on stress echocardiography with dobut-
amine infusion, a finding commented on by Wackers (2). But in this
group of patients, four (28.5%) showed improvement of contraction in
the infarcted region, a finding that should be interpreted as an evidence of
ischemia if we accept the idea that all ischemic myocardium is viable
myocardium. In addition, all patients had documented coronary artery
disease (diameter stenosis .50%), leading to the hypothesis that im-
provement of wall motion abnormalities observed in the infarct area is
consistent with the presence of hibernating myocardium.
MARCELO COELHO SHIBATA, MD
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Reply
We thank Shibata for his interesting remarks on our study of patients
with dobutamine-induced hypoperfusion without transient wall motion
abnormalities (1). Among the 14 patients without transient wall
motion abnormalities in our study, reversible perfusion defects were
confined to dyssynergic segments in 4 (29%). However, only two of
these four patients showed improved wall thickening at low dose
dobutamine. Improvement was maintained at high dose. These pa-
tients were not considered to have ischemia at echocardiography
because we used the standard criteria of new or worsening wall motion
abnormalities to define an ischemic response. As Shibata points out,
myocardial ischemia should also be considered in the presence of
evidence of myocardial viability, as in the case of improvement of a
dyssynergic segment during low dose dobutamine infusion. Although
myocardial ischemia and hibernation are related phenomena, we did
not consider the improvement at low dose dobutamine as a definite
ischemic response because we have shown (2) that only akinetic
segments with a biphasic response to dobutamine have a relatively high
prevalence of reversible thallium defects (51% vs. 9% of segments with
persistent improvement, p , 0.005) as well as a higher prevalence of
functional improvement (3) after revascularization (79% vs. 30% of
segments with persistent improvement, p , 0.005). It is possible that in
our study (1), the low rate-pressure product in the group without
transient wall motion abnormalities did not allow for the occurrence of
a biphasic response, and consequently, dyssynergic segments showed a
persistent improvement rather than a biphasic response. This obser-
vation supports our recommendation that every effort showed be made
to attain a high rate-pressure product to elicit myocardial ischemia at
dobutamine echocardiography. The conclusion of our study was that
the absence of transient wall motion abnormalities in patients with
reversible perfusion defects does not imply less severe ischemia but is
associated with a lower rate-pressure product. Inclusion of patients
with a previous myocardial infarction in our study did not seem to limit
our conclusion because we have recently demonstrated (4) that in
patients with infarct-related artery stenosis, the prevalence of peri-
infarction ischemia at dobutamine stress echocardiography, using the
standard criteria of new or worsening wall motion abnormalities, is not
significantly different from the prevalence of ischemia according to
reversible hypoperfusion on simultaneous 2-methoxy isobutyl isonitrile
(MIBI) single-photon emission computed tomography (4).
ABDOU ELHENDY, MD, PHD
Thoraxcenter Ba 302
De Molewaterplein 40
3015 GD Rotterdam, The Netherlands
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Increased Neopterin in Patients With
Chronic and Acute Coronary Syndromes
I read with interest the report by Schumacher et al. (1) regarding
plasma neopterin levels in acute and chronic coronary syndromes.
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